Related Experiment Video
Updated: Jul 3, 2026

A Catheter-Related Candida albicans Infection Model in Mouse
Published on: March 22, 2024
Treatment of central venous catheter fungal infection using liposomal amphotericin-B lock therapy
Bradley S Buckler1, Ralph N Sams, Vita L Goei
1Department of Pediatrics, Medical College of Georgia, Augusta, GA 30912, USA. bbuckler@mcg.edu
Abstract:
The current standard of care for a fungal central venous catheter infection in a pediatric patient usually requires removal without any other feasible options. Although removal may reduce the rate of Candida-associated complications, literature reviews question whether the outcomes of removal substantiate this being the standard of care. We report 6 cases of central venous catheter fungal infections treated with liposomal amphotericin-B lock therapy. These cases consisted of 4 patients, 2 of whom received recurrent therapy. In 4 of these cases, there was successful eradication of the infectious fungal agent, allowing continued use of the catheter. A controlled study of antifungal lock therapy should be considered as a potential alternative to removal.
Insights
Central venous catheter fungal infections in children often require catheter removal. Liposomal amphotericin-B lock therapy offers a potential alternative, successfully preserving catheters in most reported cases.
Area of Science:
- Pediatric Infectious Diseases
- Medical Device Infections
- Mycology
Background:
- Fungal central venous catheter infections in pediatric patients typically necessitate catheter removal as the standard treatment.
- While catheter removal can mitigate Candida-associated complications, its necessity as the sole standard of care is debated in existing literature.
Observation:
- This report details 6 cases of fungal central venous catheter infections in 4 pediatric patients.
- Two patients underwent recurrent liposomal amphotericin-B lock therapy for fungal catheter-related infections.
Findings:
- Liposomal amphotericin-B lock therapy resulted in successful eradication of fungal pathogens in 4 out of 6 cases.
- This allowed for the continued use of the central venous catheter in these patients, avoiding removal.
Implications:
- Antifungal lock therapy, specifically with liposomal amphotericin-B, presents a promising alternative to catheter removal for pediatric fungal infections.
- Further investigation through controlled studies is warranted to establish antifungal lock therapy as a viable alternative to the current standard of care.
Related Concept Videos
Antifungal Agents
Cryptococcal Meningitis
Candidiasis
Endocarditis III: Medical Management